14-day Premium Trial Subscription Try For FreeTry Free
$311.29
+32.90 (+11.82%)
At Close: May 03, 2024
Forecast Earnings Dividends Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $260.68 $322.60 Friday, 3rd May 2024 AMGN stock ended at $311.29. This is 11.82% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.50% from a day low at $308.72 to a day high of $322.60.
90 days $260.68 $329.72
52 weeks $211.73 $329.72

Historical Amgen Inc. prices

Date Open High Low Close Volume
Nov 05, 2021 $215.61 $217.42 $212.73 $213.77 2 258 629
Nov 04, 2021 $218.30 $218.45 $211.72 $214.93 2 772 409
Nov 03, 2021 $210.91 $219.25 $209.80 $218.13 3 629 394
Nov 02, 2021 $210.51 $214.72 $208.14 $214.26 3 311 758
Nov 01, 2021 $208.00 $212.09 $207.77 $209.79 3 084 005
Oct 29, 2021 $206.35 $207.70 $204.20 $206.97 2 571 941
Oct 28, 2021 $207.09 $209.49 $205.61 $207.17 2 134 105
Oct 27, 2021 $209.87 $210.40 $205.81 $206.58 1 994 222
Oct 26, 2021 $208.20 $209.98 $207.63 $208.68 1 632 569
Oct 25, 2021 $209.50 $209.82 $206.97 $207.63 1 910 893
Oct 22, 2021 $209.70 $210.50 $208.50 $209.24 1 338 358
Oct 21, 2021 $210.15 $210.26 $207.67 $208.99 1 915 849
Oct 20, 2021 $207.40 $211.59 $206.25 $209.66 2 307 968
Oct 19, 2021 $204.49 $206.90 $203.08 $206.78 2 478 971
Oct 18, 2021 $206.36 $207.00 $202.45 $203.13 2 812 533
Oct 15, 2021 $208.49 $209.02 $206.23 $207.84 3 674 937
Oct 14, 2021 $204.49 $207.50 $204.49 $206.78 3 014 977
Oct 13, 2021 $202.82 $204.89 $202.10 $203.61 3 247 195
Oct 12, 2021 $207.43 $207.56 $200.47 $201.89 3 522 681
Oct 11, 2021 $209.06 $209.89 $206.59 $206.70 1 974 930
Oct 08, 2021 $210.13 $210.18 $207.65 $208.95 2 348 462
Oct 07, 2021 $208.53 $212.45 $208.53 $209.12 3 320 080
Oct 06, 2021 $211.32 $212.08 $208.97 $209.98 2 864 836
Oct 05, 2021 $211.21 $213.99 $211.08 $211.86 2 462 355
Oct 04, 2021 $214.10 $215.64 $210.77 $211.44 2 855 024
Click to get the best stock tips daily for free!

About Amgen Inc.

Amgen. Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopaus... AMGN Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT